Table of Contents Author Guidelines Submit a Manuscript
Journal of Drug Delivery
Volume 2011, Article ID 368535, 9 pages
http://dx.doi.org/10.1155/2011/368535
Research Article

Antibody-Hapten Recognition at the Surface of Functionalized Liposomes Studied by SPR: Steric Hindrance of Pegylated Phospholipids in Stealth Liposomes Prepared for Targeted Radionuclide Delivery

1Centre de Recherche en Cancérologie Nantes-Angers (CRCNA), Université de Nantes, Inserm, UMR 892, Institut de Recherche Thérapeutique de l'Université de Nantes, 8 quai Moncousu, BP 70721, 44007 Nantes Cedex 1, France
2Plateforme Interactome & Puces à Protéines Biogenouest, Institut de Recherche Thérapeutique de l'Université de Nantes, 8 quai Moncousu, BP 70721, 44007 Nantes Cedex 1, France

Received 30 June 2010; Revised 6 October 2010; Accepted 9 December 2010

Academic Editor: Alekha K. Dash

Copyright © 2011 Eliot. P. Botosoa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [6 citations]

The following is the list of published articles that have cited the current article.

  • Rachel Oliveira, Pengxiang Zhao, Na Li, Luiz Claudio de Santa Maria, Juliette Vergnaud, Jaime Ruiz, Didier Astruc, and Gillian Barratt, “Synthesis and in vitro studies of gold nanoparticles loaded with docetaxel,” International Journal of Pharmaceutics, 2013. View at Publisher · View at Google Scholar
  • A. Rauscher, M. Frindel, C. Maurel, M. Maillasson, P. Le Saëc, H. Rajerison, J.-F. Gestin, J. Barbet, A. Faivre-Chauvet, and M. Mougin-Degraef, “Influence of pegylation and hapten location at the surface of radiolabelled liposomes on tumour immunotargeting using bispecific antibody,” Nuclear Medicine and Biology, 2013. View at Publisher · View at Google Scholar
  • Federico Perche, and Vladimir P. Torchilin, “Recent Trends in Multifunctional Liposomal Nanocarriers for Enhanced Tumor Targeting,” Journal of Drug Delivery, vol. 2013, pp. 1–32, 2013. View at Publisher · View at Google Scholar
  • Selma Djender, Aurelie Schneider, Anne Beugnet, Ronan Crepin, Klervi Even Desrumeaux, Chiara Romani, Sandrine Moutel, Franck Perez, and Ario de Marco, “Bacterial cytoplasm as an effective cell compartment for producing functional VHH-based affinity reagents and Camelidae IgG-like recombinant antibodies,” Microbial Cell Factories, vol. 13, no. 1, 2014. View at Publisher · View at Google Scholar
  • Hsin-Yi Tung, Yu-Cheng Su, Bing-Mae Chen, Pierre-Alain Burnouf, Wei-Chiao Huang, Kuo-Hsiang Chuang, Yu-Ting Yan, Tian-Lu Cheng, and Steve R. Roffler, “Selective Delivery of PEGylated Compounds to Tumor Cells by Anti-PEG Hybrid Antibodies,” Molecular Cancer Therapeutics, vol. 14, no. 6, pp. 1317–1326, 2015. View at Publisher · View at Google Scholar
  • Jacques Barbet, and Sandrine Huclier‐Markai, “Equilibrium, affinity, dissociation constants, IC5O: Facts and fantasies,” Pharmaceutical Statistics, 2019. View at Publisher · View at Google Scholar